v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance (in share) at Dec. 31, 2023   8,016,516      
Beginning balance at Dec. 31, 2023 $ 169,911 $ 8 $ 352,908 $ 0 $ (183,005)
Exercises of stock options (in shares)   5,947      
Exercises of stock options 139   139    
Stock-based compensation expense 865   865    
Net Income (Loss) (19,557)       (19,557)
Ending balance (in share) at Mar. 31, 2024   8,022,463      
Ending balance at Mar. 31, 2024 151,358 $ 8 353,912 0 (202,562)
Beginning balance (in share) at Dec. 31, 2023   8,016,516      
Beginning balance at Dec. 31, 2023 169,911 $ 8 352,908 0 (183,005)
Net Income (Loss) (41,383)        
Ending balance (in share) at Jun. 30, 2024   9,279,937      
Ending balance at Jun. 30, 2024 198,077 $ 9 422,435 21 (224,388)
Beginning balance (in share) at Mar. 31, 2024   8,022,463      
Beginning balance at Mar. 31, 2024 151,358 $ 8 353,912 0 (202,562)
Exercises of stock options (in shares)   8,191      
Exercises of stock options 172   172    
Stock-based compensation expense 967   967    
Issuance of common stock for cash in PIPE financing (in share)   1,249,283      
Issuance of common stock for cash in PIPE financing 67,385 $ 1 67,384    
Unrealized gain on investments, net of tax 21     21  
Net Income (Loss) (21,826)       (21,826)
Ending balance (in share) at Jun. 30, 2024   9,279,937      
Ending balance at Jun. 30, 2024 $ 198,077 $ 9 422,435 21 (224,388)
Beginning balance (in share) at Dec. 31, 2024 9,377,259 9,377,259      
Beginning balance at Dec. 31, 2024 $ 160,415 $ 9 426,724 268 (266,586)
Exercises of stock options (in shares)   11,643      
Exercises of stock options 172   172    
Stock-based compensation expense 1,761   1,761    
Other comprehensive income (4)     (4)  
Net Income (Loss) (23,387)       (23,387)
Ending balance (in share) at Mar. 31, 2025   9,388,902      
Ending balance at Mar. 31, 2025 $ 138,957 $ 9 428,657 264 (289,973)
Beginning balance (in share) at Dec. 31, 2024 9,377,259 9,377,259      
Beginning balance at Dec. 31, 2024 $ 160,415 $ 9 426,724 268 (266,586)
Exercises of stock options (in shares) 13,583        
Net Income (Loss) $ (49,157)        
Ending balance (in share) at Jun. 30, 2025 9,390,842 9,390,842      
Ending balance at Jun. 30, 2025 $ 115,103 $ 9 430,660 177 (315,743)
Beginning balance (in share) at Mar. 31, 2025   9,388,902      
Beginning balance at Mar. 31, 2025 138,957 $ 9 428,657 264 (289,973)
Exercises of stock options (in shares)   1,940      
Exercises of stock options 5   5    
Stock-based compensation expense 1,998   1,998    
Other comprehensive income (87)     (87)  
Net Income (Loss) $ (25,770)       (25,770)
Ending balance (in share) at Jun. 30, 2025 9,390,842 9,390,842      
Ending balance at Jun. 30, 2025 $ 115,103 $ 9 $ 430,660 $ 177 $ (315,743)